Clinical Trials Logo

Placenta Percreta clinical trials

View clinical trials related to Placenta Percreta.

Filter by:
  • None
  • Page 1

NCT ID: NCT06267599 Completed - Sutures Clinical Trials

Bladder Suture in Uterus-Sparing Surgery and Hysterectomy for Placenta Percreta

Start date: September 1, 2023
Phase:
Study type: Observational

This study aimed to evaluate the short-term and long-term complications of placenta percreta with bladder invasion. This evaluation focuses on cases where bladder dissection and ACAR-style bladder sutures were applied in cases of placenta percreta with bladder invasion that underwent uterine-sparing surgery or hysterectomy.

NCT ID: NCT04213755 Completed - Placenta Accreta Clinical Trials

ROTEM in Patients With Placenta Previa

Start date: January 1, 2020
Phase:
Study type: Observational

The rotational thromboelastogram (ROTEM) test can be performed on patients with placenta previa/accreta/increta/percreta who have a high likelihood of massive bleeding, and the predictors can be identified by comparing the patients who actually show massive bleeding with those who do not. Applying these predictive factors to pregnant women undergoing cesarean section after diagnosis of placenta previa/accreta/increta/percreta, it will be advantageous for the perioperative management because it is possible to select pregnant women with a factor of massive bleeding.

NCT ID: NCT03638024 Recruiting - Placenta Accreta Clinical Trials

Cell-free Fetal DNA Concentration in Cases of Abnormal Placental Invasion .

Start date: September 1, 2018
Phase:
Study type: Observational

Cell free fetal DNA might predict abnormal placental invasion

NCT ID: NCT02784886 Active, not recruiting - Placenta Accreta Clinical Trials

Cell-free Fetal DNA Circulating in the Maternal Plasma as a Marker for Morbidly Adherent Placenta

DNA-Accreta
Start date: November 2013
Phase: N/A
Study type: Observational

The purpose of this study is to determine whether, in a high risk population (placenta praevia and previous caesarean or prenatal suspicion of morbidly adherent placenta (MAP)), the concentration of cell-free fetal DNA circulating in the maternal plasma is significantly increased in the subgroup of morbidly adherent placenta (MAP) cases , in order to determine if the dosage of cell-free fetal DNA circulating in the maternal plasma may be a useful biological tool to detect MAP, alone or in addition to the imagery findings (ultrasonography and RMI).

NCT ID: NCT02728232 Completed - Placenta Percreta Clinical Trials

Internal Iliac Artery Ligation and Abnormally Invasive Placenta

Start date: April 2016
Phase: N/A
Study type: Interventional

This trial is set to detect the impact of bilateral internal iliac artery ligation on the amount of intra-operative blood loss during the hysterectomy procedure done for the management of abnormally invasive placenta

NCT ID: NCT02702024 Completed - Placenta Percreta Clinical Trials

The Effectiveness of Double Incision Technique in Uterus Preserving Surgery for Placenta Percreta

Start date: January 2014
Phase: N/A
Study type: Interventional

Placenta percreta is a life-threatening condition that patients are under risk of massive bleeding. It readily necessitates very complicated surgery even leads to mortality. Cesarean hysterectomy is the procedure that is acknowledged worldwide, however, recent studies discussing conservative treatment with segmental resections were published. Fetal extraction and segmental resection could be performed from same (single uterine incision) or two different (double uterine incision) incisions. In this study, the investigators aimed to evaluate the effectiveness and the results of double uterine incision.